The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies…
October 10, 2025 17:16 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…
October 10, 2025 04:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – Q3 2025…
October 10, 2025 02:15 ET | Source: IDEX BIOMETRICS ASA Mumbai, India – IDEX Biometrics is proud to announce the…
Event to be held October 14th at 4 p.m. EST October 09, 2025 07:00 ET | Source: Gain Therapeutics, Inc.…
October 09, 2025 07:00 ET | Source: Axsome Therapeutics, Inc. NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics,…
October 09, 2025 04:00 ET | Source: iManage CHICAGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to…
October 08, 2025 09:00 ET | Source: Pluri Inc. State-backed collaboration outlines a multi-phase, capital-light path from cell line development…
October 08, 2025 08:00 ET | Source: Silicon Motion Technology Corporation TAIPEI, Taiwan and MILPITAS, Calif., Oct. 08, 2025 (GLOBE…
October 08, 2025 08:00 ET | Source: Rocket Doctor AI Inc. Rocket Doctor has signed contracts and is in credentialing…